Marilyn M. Barbour

Is a History of Depressive Symptoms Associated With an Increased Risk of Infertility in Women

Researchers have reported an association between self-reported antidepressant use and increased risk of ovulatory infertility but could not control for confounding by the drug indication. We evaluated the role of depressive symptoms in the development of infertility. We recontacted a population-based sample of Pawtucket Heart Health Program (PHHP) health survey respondents to perform this case-control study. Self-reported infertility was defined as an inability to conceive after 12 months of unprotected intercourse. Controls were women who reported at least one pregnancy. The index age for infertile women was the age at which they first experienced fertility problems, and for the fertile women it was the age of their first pregnancy. History of depressive symptoms was based on self-report before the index age. Women with a history of depressive symptoms were nearly twice as likely to report infertility relative to women without a history of depressive symptoms before the index age after controlling for potential confounders (90% confidence interval: 0.9-3.2). Our data suggest that depressive symptoms as well as the drugs used to treat these conditions may play an important role in the pathogenesis of infertility. The association between depressive symptoms and infertility should be explored further.

Influence of exercise intensity on the presence, distribution, and size of thallium-201 defects☆

The effects of two levels of exercise intensity on the size and location of thallium-201 defects were compared in 22 patients with known ischemic coronary artery disease. A symptom-limited incremental exercise test was performed followed (greater than 48 hours) by submaximal steady-state exercise at 70% of the peak heart rate achieved during the incremental test. Planar thallium-201 myocardial scans obtained after each protocol were analyzed by means of both visual qualitative and computerized quantitative methods. After incremental exercise all patients exhibited reversible thallium-201 defects, and submaximal exercise still resulted in reversible defects in 20 (91%) patients. However, the size of the ischemic area and the degree of ischemia were significantly reduced by both qualitative and quantitative criteria after submaximal exercise. Therefore interpretation of thallium-201 scans with regard to severity of disease and prognosis should take into account exercise intensity.

Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort.

Study Objective. To examine the association of commonly used drugs with erectile dysfunction (ED) at two time points.

Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers

OBJECTIVE Our purpose was to investigate whether selection of healthy women for postmenopausal estrogen therapy may confound observational studies of estrogen use and cardiovascular disease risk. STUDY DESIGN Data were obtained from baseline (1981 to 1984) and follow-up (1990 to 1992) health surveys of two cohorts randomly selected from communities in southeastern New England. At follow-up postmenopausal women > or = 40 years old were categorized as current users (n = 70) or nonusers (n = 772) of noncontraceptive estrogen. Users and nonusers were compared on both prior characteristics from the baseline surveys and current characteristics measured at follow-up by use of analysis of covariance. RESULTS Prior levels of total and high-density lipoprotein cholesterol, body mass index, and blood pressure were similar for estrogen users and nonusers. Estrogen users were less likely to have smoked and more likely to have had their cholesterol checked and to exercise regularly. These differences were more pronounced for current characteristics than for baseline characteristics. CONCLUSIONS Selection of healthy women for treatment may not fully explain the apparent protective effect of estrogen replacement on cardiovascular risk. However, more healthy profiles among estrogen users may inflate the apparent benefit of treatment in observational studies.

Is the use of psychotropic drugs associated with increased risk of ischemic heart disease

Earlier reports of associations between panic disorder, depression, and ischemic heart disease have not evaluated the role of the drugs used to treat these conditions. As part of a larger study on reducing cardiovascular disease in an entire community, we estimated the association between psychotropic drugs and ischemic heart disease in a large community-based population using a cohort study design. We defined exposure as current use of psychotropic medications at the time of the health interview. We determined ischemic heart disease by International Classification of Diseases, 9th revision, Clinical Modification, codes and by an epidemiologic algorithm using clinical diagnostic criteria. An elevated risk for clinically significant ischemic cardiac events was moderately associated with benzodiazepine use [relative risk (RR) = 2.0; 90% confidence interval (CI) = 1.1–3.9] and strongly associated with antidepressant use (RR = 5.7; 90% CI = 2.6–12.8), although the latter estimate was based on only six antidepressant users who had an ischemic event.

Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease☆

Studies using dobutamine thallium-201 myocardial perfusion imaging have suggested a high sensitivity and specificity for the detection of coronary artery disease. However, few data are available comparing dobutamine with exercise stress for the detection and localization of perfusion defects. This study compared the effects of dobutamine and exercise stress using technetium-99m sestamibi single-photon emission computed tomographic imaging in the same patients in a prospective crossover trial. Twenty-four patients with a high likelihood of coronary artery disease underwent tomographic myocardial imaging at rest, after symptom-limited treadmill exercise, and after intravenous dobutamine (maximum 30 micrograms/kg/min). Tomograms of the left ventricle were divided into 20 segments and were interpreted without knowledge of patient identity or stress protocol. Dobutamine was well tolerated by all patients. Segment-by-segment concordance between exercise and dobutamine images was highly significant (kappa = 0.56, p < 0.0001). Global first-order agreement (normal vs abnormal) between exercise and dobutamine studies was 96% (kappa = 0.65, p = 0.02); global second-order agreement (normal vs fixed vs ischemic defect) was 88% (kappa = 0.45, p = 0.02). Regional first- and second-order agreement were 96 and 93%, respectively (p < 0.001 for both). Twenty patients underwent coronary angiography. Comparisons between exercise and angiography and between dobutamine and angiography were similar for both global agreement (95 vs 100%, p = NS) and regional agreement (77 vs 72%, p = NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Comparison of chest pain, electrocardiographic changes and thallium-201 scintigraphy during varying exercise intensities in men with stable angina pectoris

This study was performed to evaluate the presence of angina pectoris, electrocardiographic changes and reversible thallium-201 defects resulting from 2 different levels of exercise in 19 patients with known coronary artery disease and evidence of exercise-induced ischemia. The exercise protocols consisted of a symptom-limited incremental exercise test (Bruce protocol) followed within 3 to 14 days by a submaximal, steady-state exercise test performed at 70% of the maximal heart rate achieved during the Bruce protocol. The presence and time of onset of angina and electrocardiographic changes (greater than or equal to 0.1 mV ST-segment depression) as well as oxygen uptake, exercise duration and pressure-rate product were recorded. Thallium-201 (2.5 to 3.0 mCi) was injected during the last minute of exercise during both protocols, and the images were analyzed using both computer-assisted quantitation and visual interpretations. Incremental exercise resulted in anginal symptoms in 84% of patients, and electrocardiographic changes and reversible thallium-201 defects in all patients. In contrast, submaximal exercise produced anginal symptoms in only 26% (p less than 0.01) and electrocardiographic changes in only 47% (p less than 0.05), but resulted in thallium-201 defects in 89% of patients (p = not significant). The locations of the thallium-201 defects, when present, were not different between the 2 exercise protocols. These findings confirm the sequence of the ischemic cascade using 2 levels of exercise and demonstrate that the cascade theory is applicable during varying ischemic intensities in the same patient.

Is Antidepressant Use Changing? Prevalence and Clinical Correlates in Two New England Communities

We attempted to determine whether the prevalence of antidepressant use had increased in population‐based samples between 1981 and 1993, and compared the characteristics of antidepressant users and nonusers. Data were derived from six biennial, random sample, cross‐sectional household surveys conducted between 1981 and 1993 in two southeastern New England communities. For each survey, point prevalence estimates were determined for the major antidepressant categories. Antidepressant users were most likely to be women, slightly older, and less likely to be employed than nonusers (p<0.0001). Comorbid conditions and concurrent drug therapy were present more frequently among users. The overall prevalence of antidepressant use per 1000 population increased from 7.8 (95% confidence interval 4.3, 11.3) in 1981–1982 to 31.4 (95% CI 23.9, 38.9) in 1992–1993, especially among women and respondents between ages 40 and 59 years.

Antiischemic Therapy in Patients with Coronary Heart Disease Living in Long-term Care

We evaluated antiischemic therapy in elderly nursing home residents with a diagnosis of coronary heart disease (CHD) using a population‐based data base with over 300,000 residents (1992–1995) of all Medicare/Medicaid‐certified nursing homes of five states. We identified 72,263 patients age 65 years or older with a diagnosis of CHD. We examined data collected with the federally mandated Minimum Data Set, drug information, and Medicare hospital claims. Antiischemics were defined as (β‐adrenergic blockers, long‐term nitrates, and calcium channel blockers. We determined factors associated with use of the drugs by logistic regression. Antiischemic therapy was inversely related to age and cognitive and physical functioning, but positively associated with recent hospitalization and concomitant cardiovascular diseases. (β‐Adrenergic blockers were least likely to be administered regardless of age, gender, or cognitive or physical function. We conclude that antiischemic therapy in nursing home residents may not be optimal.

Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure?

OBJECTIVES: Concomitant ischemic heart disease (IHD) is common in older individuals with heart failure (HF). We estimated the effect of aspirin use on the rate of mortality, morbidity, and decline in physical functioning in nursing home residents with HF taking angiotensin‐converting enzyme (ACE) inhibitors.